Scott Courtney - Medical Developments Chief Officer

All Insiders . Australia . 
Stock . Medical Developments International . Stakeholders . Insider . Scott Courtney
MVP Stock   0.42  0.01  2.33%   

Executive

Scott Courtney is Chief Officer of Medical Developments International
Address 4 Caribbean Drive, Scoresby, VIC, Australia, 3179
Phone61 3 9547 1888
Webhttps://medicaldev.com

Medical Developments Management Efficiency

The company has return on total asset (ROA) of (0.1121) % which means that it has lost $0.1121 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6453) %, meaning that it generated substantial loss on money invested by shareholders. Medical Developments' management efficiency ratios could be used to measure how well Medical Developments manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Medical Developments' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 2.9 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 5.1 M in 2024.
Medical Developments International has accumulated 2.29 M in total debt. Debt can assist Medical Developments until it has trouble settling it off, either with new capital or with free cash flow. So, Medical Developments' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medical Developments sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medical to invest in growth at high rates of return. When we think about Medical Developments' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

LLB BAWestpac Banking
53
Justin McCarthyWestpac Banking
N/A
Russell GregoryTalisman Mining
N/A
BSc BScTelix Pharmaceuticals
N/A
Tim SharpTalisman Mining
N/A
Christine ParkerWestpac Banking
64
BBus FCPATelix Pharmaceuticals
58
Mary JesselTelix Pharmaceuticals
N/A
Meredith CroweTelix Pharmaceuticals
N/A
Craig UlrickTelix Pharmaceuticals
N/A
Meredith BDESTelix Pharmaceuticals
N/A
AGIA ACGTelix Pharmaceuticals
N/A
SlatteryRidley
N/A
Ryan CFAWestpac Banking
61
Sandie ClowesRidley
N/A
Lena LLBTelix Pharmaceuticals
N/A
MBA MDTelix Pharmaceuticals
55
Kyahn BATelix Pharmaceuticals
N/A
Jeremy CowanRidley
N/A
BAgrEc GAICDRidley
N/A
Steve LeggettPeel Mining
N/A
Medical Developments International (MVP) is traded on Australian Securities Exchange in Australia and employs 9 people. Medical Developments is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Return On Equity-0.65
Return On Asset-0.11

Medical Developments Leadership Team

Elected by the shareholders, the Medical Developments' board of directors comprises two types of representatives: Medical Developments inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medical. The board's role is to monitor Medical Developments' management team and ensure that shareholders' interests are well served. Medical Developments' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medical Developments' outside directors are responsible for providing unbiased perspectives on the board's policies.
Wayne Pearce, Head Production
Brent MacGregor, Chief Officer
Wai Chi, Head Affairs
Stefaan Schatteman, Head Europe
Anita James, Chief Officer
Greer Lucas, Head Culture
Tara Eaton, General Secretary
Matthew Cramer, Chief Chain
Scott Courtney, Chief Officer

Medical Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medical Developments a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.65
Return On Asset-0.11
Profit Margin(1.24) %
Operating Margin(0.15) %
Current Valuation39.3 M
Shares Outstanding112.66 M
Shares Owned By Insiders16.77 %
Shares Owned By Institutions25.14 %
Price To Book1.02 X
Price To Sales1.41 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Medical Stock Analysis

When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY